glp 1 agonist saxenda First Generic GLP-1 Injection OK'd for Weight Loss FDA Approves First Generic GLP-1

One in 8 American adults reports using a glucagon-like peptide 1 receptor agonist (GLP-1RA) medication, and prescriptions continue to increase due to these drugs effectiveness in reducing cardiovascular mortality and treating diabetes and obesity

Individuals on anticoagulant medications should consult their healthcare providers

doi: 10.1097/JGP.0b013e31822001c1 22 CabouC.BurcelinR

GLP-1RAs affects the central nervous system, including reducing appetite, improving diet control, increasing satiety, reducing calorie intake, etc

Questions about practical considerations: What is the titration schedule, and how long before I reach the target dose

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial